• Treatments and Therapies

  United Therapeutics, MannKind Close Deal for PAH Device

  Posted by Pulmonary Hypertension News Moderator on September 7, 2018 at 7:23 am

  United Therapeutics and MannKind have established an exclusive licensing and collaboration agreement to develop treprostinil-Technosphere device for PAH treatment.

  Click here to read more about this story.

  What are your thoughts on this news?

  replied 5 years, 7 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply